查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573948

胜任细胞市场：按应用、电池类型、最终用户、产品供应、技术 - 全球预测 2025-2030

Competent Cells Market by Application (Biotechnology, Clinical Research, Industrial), Cell Type (E. coli Competent Cells, Mammalian Competent Cells, Other Bacterial Competent Cells), End User, Product Offerings, Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胜任细胞市场价值为20.1亿美元，预计到2024年将达到22.1亿美元，复合年增长率为8.76%，到2030年将达到36.2亿美元。

胜任细胞在分子生物学中对于转化过程中吸收外源DNA至关重要，并且在生物技术研究、基因工程和药物开发中发挥重要作用。这些细胞经过化学或电处理以增加膜对 DNA 的渗透性。胜任细胞的需求涵盖克隆技术、蛋白质表现和基因修饰等领域的应用，使其成为专注于基因工程和合成生物学的实验室的基本工具。最终用途范围涵盖学术研究机构、製药公司和生物技术公司，这些细胞对于基因克隆和药物製造等关键业务至关重要。

主要市场统计
基准年[2023] 20.1亿美元
预计年份 [2024] 22.1亿美元
预测年份 [2030] 36.2亿美元
复合年增长率（%） 8.76%

根据市场洞察，胜任细胞市场的成长是由合成生物学的进步、重组技术资金的增加以及生物製药需求的增加所推动的。基因工程的不断创新正在增加对胜任细胞的需求并推动市场扩张。 CRISPR 技术的进步和下一代疗法的开发带来了商机，为有兴趣的相关人员创造了潜在的伙伴关係和投资途径。为了抓住新的成长机会，建议专注于市场扩张，特别是在亚太地区，因为生物技术领域的快速成长和政府的积极倡议。

相反，存在一些可能抑制市场渗透的限制因素，例如与生产相关的高成本以及有关基因操纵的道德问题。监管障碍和严格的核准流程带来了额外的挑战。创新和研究可以集中在提高 DNA 摄取效率、开发具有成本效益的高效菌株以及改进冷冻保存技术以维持细胞活力。透过简化生产流程和投资自动化平台来优化製造和可扩展性。市场的本质是高度动态的，其特点是技术快速进步以及现有和新兴参与企业争夺市场占有率的竞争格局。透过将技术创新与行业需求结合并解决监管挑战，公司可以实现永续成长和竞争优势。

市场动态：揭示快速发展的胜任细胞市场的关键市场洞察

胜任细胞市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大胜任细胞在基因治疗和个人化医疗的应用
    • 慢性疾病盛行率上升，需要使用胜任细胞进行高阶研究
    • 开发具有更高转化效率的新胜任细胞系
    • 研究机构和生物技术公司之间加强合作以改善细胞技术
  • 市场限制因素
    • 一些胜任细胞系的转化效率有限，限制了它们在复杂遗传实验中的使用
    • 与生产和储存相关的高成本阻碍了它们在小规模研究和学术研究中的应用。
  • 市场机会
    • 提高工业规模生物技术过程中胜任细胞的效率与产量
    • 利用高性能胜任细胞拓展农业生物技术的市场潜力
    • 胜任细胞在环境生物技术污染防治与生物修復的应用
  • 市场问题
    • 使用胜任细胞产生的转基因生物 (GMO) 的核准和商业化的监管障碍
    • 关于感受胜任细胞技术促进的基因改造的伦理问题和公众认知问题

波特五力：驾驭胜任细胞市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解胜任细胞市场的外部影响

外部宏观环境因素在塑造胜任细胞市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解感受胜任细胞市场的竞争状况

对胜任细胞市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位胜任细胞市场供应商的绩效评估

FPNV定位矩阵是评估胜任细胞市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了胜任细胞市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，胜任细胞市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 胜任细胞在基因治疗和个人化医疗的应用不断增加
      • 慢性疾病的增加需要使用胜任细胞进行高阶研究
      • 开发具有更高转化效率的新感受态细胞株
      • 扩大研究机构与生物技术公司之间的合作以改善细胞技术
    • 抑制因素
      • 一些感受态细胞株的有限转化效率限制了它们在复杂遗传实验中的使用
      • 感受胜任细胞生产和储存的高成本阻碍了小规模和学术研究应用
    • 机会
      • 提高工业规模生物技术过程中胜任细胞的效率与产量
      • 拓展高性能农业生物技术胜任细胞的市场潜力
      • 胜任细胞在环境生物技术中污染控制和生物修復的应用
    • 任务
      • 使用胜任细胞产生的基因改造生物 (GMO) 的核准和商业化的监管障碍
      • 使用胜任细胞技术进行基因改造的伦理问题和公众意识问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章胜任细胞市场：依应用分类

  • 介绍
  • 生物技术
    • 基因工程
    • 蛋白质表现
  • 临床研究
    • 诊断
    • 治疗开发
  • 产业
    • 生物转化
    • 发酵
  • 製药
    • 药物发现
    • 疫苗开发
  • 研究与开发
    • 生物资讯学
    • 微生物学
    • 分子生物学

第七章胜任细胞市场：依细胞类型

  • 介绍
  • 大肠桿菌胜任细胞
    • 化学感受态大肠桿菌
    • 电感受态大肠桿菌
  • 哺乳动物胜任细胞
    • CHO细胞
    • HEK细胞
  • 其他细菌胜任细胞
    • 枯草桿菌
    • 乳酸乳球菌
  • 酵母胜任细胞
    • P. pastoris
    • S. cerevisiae

第八章胜任细胞市场：依最终用户分类

  • 介绍
  • 学术研究所
    • 非营利研究中心
    • 大学
  • 农业研究所
  • 生技公司
    • 成熟的生物技术
    • Start-Ups生技公司
  • 合约研究组织
  • 製药公司

第九章胜任细胞市场：依产品分类

  • 介绍
  • 胜任细胞套件
    • 化学转换套件
    • 电穿孔试剂套件
  • 试剂及耗材
    • 抗生素
    • 生长培养基
    • 质体
  • 服务
    • 自订克隆服务
    • 自订蛋白表达服务

第十章胜任细胞市场：依技术分类

  • 介绍
  • 化学转化
  • 电穿孔

第十一章美洲的胜任细胞市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太胜任细胞市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的胜任细胞市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C00F0

The Competent Cells Market was valued at USD 2.01 billion in 2023, expected to reach USD 2.21 billion in 2024, and is projected to grow at a CAGR of 8.76%, to USD 3.62 billion by 2030.

Competent cells are essential in molecular biology for the uptake of foreign DNA during the transformation process, with a significant scope in biotechnology research, genetic engineering, and pharmaceutical development. These cells are chemically or electrically treated to increase membrane permeability to DNA. The necessity of competent cells spans their application in cloning techniques, protein expression, and genetic modification, serving as fundamental tools for laboratories focused on genetic engineering and synthetic biology. The end-use scope covers academic research institutions, pharmaceutical companies, and biotechnology firms, with these cells critical for crucial operations like gene cloning and pharmaceutical production.

KEY MARKET STATISTICS
Base Year [2023] USD 2.01 billion
Estimated Year [2024] USD 2.21 billion
Forecast Year [2030] USD 3.62 billion
CAGR (%) 8.76%

Market insights reveal the growth of the competent cells market driven by advances in synthetic biology, increased funding for recombinant technology, and rising demand for biopharmaceuticals. Continued innovation in genetic engineering amplifies the demand for competent cells, propelling market expansion. Opportunities arise from advancements in CRISPR technologies and next-generation therapeutic development, creating potential partnerships and investment avenues for stakeholders. Emphasizing regional market expansion, particularly in Asia-Pacific due to burgeoning biotech sectors and favorable government initiatives, is recommended to capture emerging growth opportunities.

Conversely, limitations include high costs associated with production and ethical concerns regarding genetic manipulation that could stymie market advancement. Regulatory hurdles and stringent approval processes present further challenges. Innovation and research can focus on enhancing the efficiency of DNA uptake, developing cost-effective and higher competency strains, and improving cryopreservation techniques for preserving cell viability. Streamlining production processes and investing in automated platforms can optimize manufacturing and scalability. The nature of the market is highly dynamic, characterized by rapid technological advancements and a competitive landscape filled with established and emerging players vying for market share. By aligning technological innovations with industry demands and addressing regulatory challenges, companies can achieve sustained growth and competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Competent Cells Market

The Competent Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • increased application of competent cells in gene therapy and personalized medicine
    • rising prevalence of chronic diseases necessitating advanced research using competent cells
    • development of new competent cell strains with enhanced transformation efficiency
    • growing collaborations between research institutions and biotechnology companies to improve cell technologies
  • Market Restraints
    • Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
    • High costs associated with production and storage of competent cells hindering small-scale and academic research applications
  • Market Opportunities
    • Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
    • Market potential in expanding agricultural biotechnology with high-performance competent cells
    • Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
  • Market Challenges
    • Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
    • Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies

Porter's Five Forces: A Strategic Tool for Navigating the Competent Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Competent Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Competent Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Competent Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Competent Cells Market

A detailed market share analysis in the Competent Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Competent Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Competent Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Competent Cells Market

A strategic analysis of the Competent Cells Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Competent Cells Market, highlighting leading vendors and their innovative profiles. These include Addgene, Agilent Technologies, Bio-Rad Laboratories, BioDynamics Laboratory, Bioneer Corporation, Cayman Chemical Company, Cell Applications, Edge BioSystems, GenScript Biotech, Lucigen Corporation, Merck Group, New England Biolabs, OriGene Technologies, Promega Corporation, QIAGEN, Scarab Genomics, Takara Bio, Thermo Fisher Scientific, Yeastern Biotech, and Zymo Research.

Market Segmentation & Coverage

This research report categorizes the Competent Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Biotechnology, Clinical Research, Industrial, Pharmaceutical, and Research and Development. The Biotechnology is further studied across Genetic Engineering and Protein Expression. The Clinical Research is further studied across Diagnostics and Therapeutic Development. The Industrial is further studied across Bioconversion and Fermentation. The Pharmaceutical is further studied across Drug Discovery and Vaccine Development. The Research and Development is further studied across Bioinformatics, Microbiology, and Molecular Biology.
  • Based on Cell Type, market is studied across E. coli Competent Cells, Mammalian Competent Cells, Other Bacterial Competent Cells, and Yeast Competent Cells. The E. coli Competent Cells is further studied across Chemically Competent E. coli and Electrocompetent E. coli. The Mammalian Competent Cells is further studied across CHO Cells and HEK Cells. The Other Bacterial Competent Cells is further studied across B. subtilis and L. lactis. The Yeast Competent Cells is further studied across P. pastoris and S. cerevisiae.
  • Based on End User, market is studied across Academic and Research Institutes, Agricultural Research Organizations, Biotech Companies, Contract Research Organizations, and Pharmaceutical Companies. The Academic and Research Institutes is further studied across Non-profit Research Centers and Universities. The Biotech Companies is further studied across Established Biotechs and Startup Biotechs.
  • Based on Product Offerings, market is studied across Competent Cell Kits, Reagents and Consumables, and Services. The Competent Cell Kits is further studied across Chemical Transformation Kits and Electroporation Kits. The Reagents and Consumables is further studied across Antibiotics, Growth Media, and Plasmids. The Services is further studied across Custom Cloning Services and Custom Protein Expression Services.
  • Based on Technology, market is studied across Chemical Transformation and Electroporation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. increased application of competent cells in gene therapy and personalized medicine
      • 5.1.1.2. rising prevalence of chronic diseases necessitating advanced research using competent cells
      • 5.1.1.3. development of new competent cell strains with enhanced transformation efficiency
      • 5.1.1.4. growing collaborations between research institutions and biotechnology companies to improve cell technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
      • 5.1.2.2. High costs associated with production and storage of competent cells hindering small-scale and academic research applications
    • 5.1.3. Opportunities
      • 5.1.3.1. Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
      • 5.1.3.2. Market potential in expanding agricultural biotechnology with high-performance competent cells
      • 5.1.3.3. Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
      • 5.1.4.2. Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Competent Cells Market, by Application

  • 6.1. Introduction
  • 6.2. Biotechnology
    • 6.2.1. Genetic Engineering
    • 6.2.2. Protein Expression
  • 6.3. Clinical Research
    • 6.3.1. Diagnostics
    • 6.3.2. Therapeutic Development
  • 6.4. Industrial
    • 6.4.1. Bioconversion
    • 6.4.2. Fermentation
  • 6.5. Pharmaceutical
    • 6.5.1. Drug Discovery
    • 6.5.2. Vaccine Development
  • 6.6. Research and Development
    • 6.6.1. Bioinformatics
    • 6.6.2. Microbiology
    • 6.6.3. Molecular Biology

7. Competent Cells Market, by Cell Type

  • 7.1. Introduction
  • 7.2. E. coli Competent Cells
    • 7.2.1. Chemically Competent E. coli
    • 7.2.2. Electrocompetent E. coli
  • 7.3. Mammalian Competent Cells
    • 7.3.1. CHO Cells
    • 7.3.2. HEK Cells
  • 7.4. Other Bacterial Competent Cells
    • 7.4.1. B. subtilis
    • 7.4.2. L. lactis
  • 7.5. Yeast Competent Cells
    • 7.5.1. P. pastoris
    • 7.5.2. S. cerevisiae

8. Competent Cells Market, by End User

  • 8.1. Introduction
  • 8.2. Academic and Research Institutes
    • 8.2.1. Non-profit Research Centers
    • 8.2.2. Universities
  • 8.3. Agricultural Research Organizations
  • 8.4. Biotech Companies
    • 8.4.1. Established Biotechs
    • 8.4.2. Startup Biotechs
  • 8.5. Contract Research Organizations
  • 8.6. Pharmaceutical Companies

9. Competent Cells Market, by Product Offerings

  • 9.1. Introduction
  • 9.2. Competent Cell Kits
    • 9.2.1. Chemical Transformation Kits
    • 9.2.2. Electroporation Kits
  • 9.3. Reagents and Consumables
    • 9.3.1. Antibiotics
    • 9.3.2. Growth Media
    • 9.3.3. Plasmids
  • 9.4. Services
    • 9.4.1. Custom Cloning Services
    • 9.4.2. Custom Protein Expression Services

10. Competent Cells Market, by Technology

  • 10.1. Introduction
  • 10.2. Chemical Transformation
  • 10.3. Electroporation

11. Americas Competent Cells Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Competent Cells Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Competent Cells Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addgene
  • 2. Agilent Technologies
  • 3. Bio-Rad Laboratories
  • 4. BioDynamics Laboratory
  • 5. Bioneer Corporation
  • 6. Cayman Chemical Company
  • 7. Cell Applications
  • 8. Edge BioSystems
  • 9. GenScript Biotech
  • 10. Lucigen Corporation
  • 11. Merck Group
  • 12. New England Biolabs
  • 13. OriGene Technologies
  • 14. Promega Corporation
  • 15. QIAGEN
  • 16. Scarab Genomics
  • 17. Takara Bio
  • 18. Thermo Fisher Scientific
  • 19. Yeastern Biotech
  • 20. Zymo Research

LIST OF FIGURES

  • FIGURE 1. COMPETENT CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. COMPETENT CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. COMPETENT CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. COMPETENT CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPETENT CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPETENT CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY PROTEIN EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOCONVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPETENT CELLS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPETENT CELLS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPETENT CELLS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COMPETENT CELLS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPETENT CELLS MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICALLY COMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROCOMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COMPETENT CELLS MARKET SIZE, BY HEK CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COMPETENT CELLS MARKET SIZE, BY B. SUBTILIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COMPETENT CELLS MARKET SIZE, BY L. LACTIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL COMPETENT CELLS MARKET SIZE, BY P. PASTORIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL COMPETENT CELLS MARKET SIZE, BY S. CEREVISIAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL COMPETENT CELLS MARKET SIZE, BY NON-PROFIT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL COMPETENT CELLS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL COMPETENT CELLS MARKET SIZE, BY AGRICULTURAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL COMPETENT CELLS MARKET SIZE, BY ESTABLISHED BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL COMPETENT CELLS MARKET SIZE, BY STARTUP BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL COMPETENT CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL COMPETENT CELLS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL COMPETENT CELLS MARKET SIZE, BY GROWTH MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL COMPETENT CELLS MARKET SIZE, BY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM CLONING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM PROTEIN EXPRESSION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. ARGENTINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ARGENTINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 130. BRAZIL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. BRAZIL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. BRAZIL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 147. CANADA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 148. CANADA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 149. CANADA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. CANADA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. CANADA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. MEXICO COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 165. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 166. MEXICO COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 167. MEXICO COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 168. MEXICO COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. MEXICO COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. MEXICO COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED STATES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED STATES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED STATES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED STATES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED STATES COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED STATES COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 220. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 222. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 225. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 226. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 227. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 234. CHINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 235. CHINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. CHINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. CHINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 238. CHINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 239. CHINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 240. CHINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 241. CHINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. CHINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 243. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 244. CHINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 245. CHINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 246. CHINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. CHINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. CHINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. INDIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 252. INDIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 253. INDIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 254. INDIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. INDIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. INDIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 257. INDIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 258. INDIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 259. INDIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 260. INDIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. INDIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 262. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 263. INDIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 264. INDIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 265. INDIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. INDIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. INDIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. INDONESIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. INDONESIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 271. INDONESIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 272. INDONESIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 273. INDONESIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 274. INDONESIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. INDONESIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 276. INDONESIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 277. INDONESIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 278. INDONESIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 279. INDONESIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. INDONESIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 281. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 282. INDONESIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 283. INDONESIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 284. INDONESIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 285. INDONESIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 286. INDONESIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. JAPAN COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. JAPAN COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 290. JAPAN COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 291. JAPAN COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 292. JAPAN COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 293. JAPAN COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. JAPAN COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 295. JAPAN COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 296. JAPAN COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 297. JAPAN COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 298. JAPAN COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. JAPAN COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 300. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 301. JAPAN COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 302. JAPAN COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 303. JAPAN COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. JAPAN COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 305. JAPAN COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. MALAYSIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 309. MALAYSIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 310. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 311. MALAYSIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 312. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. MALAYSIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 314. MALAYSIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 315. MALAYSIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 316. MALAYSIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 317. MALAYSIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. MALAYSIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 319. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 320. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 321. MALAYSIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 322. MALAYSIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 323. MALAYSIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 324. MALAYSIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 328. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 330. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 331. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 333. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 334. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 335. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 336. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 337. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 338. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 339. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 340. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 341. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 342. PHILIPPINES COMPETENT CELLS MARKE